These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 28280261)

  • 1. Non-kinase targets of protein kinase inhibitors.
    Munoz L
    Nat Rev Drug Discov; 2017 Jun; 16(6):424-440. PubMed ID: 28280261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A broad activity screen in support of a chemogenomic map for kinase signalling research and drug discovery.
    Gao Y; Davies SP; Augustin M; Woodward A; Patel UA; Kovelman R; Harvey KJ
    Biochem J; 2013 Apr; 451(2):313-28. PubMed ID: 23398362
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unexpected off-targets and paradoxical pathway activation by kinase inhibitors.
    Hantschel O
    ACS Chem Biol; 2015 Jan; 10(1):234-45. PubMed ID: 25531586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-throughput screening for kinase inhibitors.
    von Ahsen O; Bömer U
    Chembiochem; 2005 Mar; 6(3):481-90. PubMed ID: 15742384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein Kinase Selectivity Profiling Using Microfluid Mobility Shift Assays.
    Drueckes P
    Methods Mol Biol; 2016; 1439():143-57. PubMed ID: 27316993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting kinase signaling pathways with constrained peptide scaffolds.
    Hanold LE; Fulton MD; Kennedy EJ
    Pharmacol Ther; 2017 May; 173():159-170. PubMed ID: 28185915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there a future for Aurora kinase inhibitors for anticancer therapy?
    Carpinelli P; Moll J
    Curr Opin Drug Discov Devel; 2009 Jul; 12(4):533-42. PubMed ID: 19562649
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinase-targeted libraries: the design and synthesis of novel, potent, and selective kinase inhibitors.
    Akritopoulou-Zanze I; Hajduk PJ
    Drug Discov Today; 2009 Mar; 14(5-6):291-7. PubMed ID: 19121409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unprecedently Large-Scale Kinase Inhibitor Set Enabling the Accurate Prediction of Compound-Kinase Activities: A Way toward Selective Promiscuity by Design?
    Christmann-Franck S; van Westen GJ; Papadatos G; Beltran Escudie F; Roberts A; Overington JP; Domine D
    J Chem Inf Model; 2016 Sep; 56(9):1654-75. PubMed ID: 27482722
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of kinase inhibitor selectivity using a thermodynamics-based partition index.
    Cheng AC; Eksterowicz J; Geuns-Meyer S; Sun Y
    J Med Chem; 2010 Jun; 53(11):4502-10. PubMed ID: 20459125
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Checkpoint kinase inhibitors: a review of the patent literature.
    Janetka JW; Ashwell S
    Expert Opin Ther Pat; 2009 Feb; 19(2):165-97. PubMed ID: 19441917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The resistance tetrad: amino acid hotspots for kinome-wide exploitation of drug-resistant protein kinase alleles.
    Bailey FP; Andreev VI; Eyers PA
    Methods Enzymol; 2014; 548():117-46. PubMed ID: 25399644
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-kinase off-target inhibitory activities of clinically-relevant kinase inhibitors.
    Brauer NR; Kempen AL; Hernandez D; Sintim HO
    Eur J Med Chem; 2024 Sep; 275():116540. PubMed ID: 38852338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extending kinome coverage by analysis of kinase inhibitor broad profiling data.
    Jacoby E; Tresadern G; Bembenek S; Wroblowski B; Buyck C; Neefs JM; Rassokhin D; Poncelet A; Hunt J; van Vlijmen H
    Drug Discov Today; 2015 Jun; 20(6):652-8. PubMed ID: 25596550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pocketome of human kinases: prioritizing the ATP binding sites of (yet) untapped protein kinases for drug discovery.
    Volkamer A; Eid S; Turk S; Jaeger S; Rippmann F; Fulle S
    J Chem Inf Model; 2015 Mar; 55(3):538-49. PubMed ID: 25557645
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benzofuran Small Molecules as Potential Inhibitors of Human Protein Kinases. A Review.
    Kwiecień H; Goszczyńska A; Rokosz P
    Curr Pharm Des; 2016; 22(7):879-94. PubMed ID: 26648467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Editorial: Recent Advances in the Field of Kinases and Kinase Inhibitors.
    Huang Z; Lee MH
    Curr Pharm Des; 2017 Nov; 23(29):4207-4208. PubMed ID: 29231803
    [No Abstract]   [Full Text] [Related]  

  • 18. Novel kinase inhibitors by reshuffling ligand functionalities across the human kinome.
    Vidović D; Muskal SM; Schürer SC
    J Chem Inf Model; 2012 Dec; 52(12):3107-15. PubMed ID: 23121521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 25 years of small molecular weight kinase inhibitors: potentials and limitations.
    Fabbro D
    Mol Pharmacol; 2015 May; 87(5):766-75. PubMed ID: 25549667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessing Lysine and Cysteine Reactivities for Designing Targeted Covalent Kinase Inhibitors.
    Liu R; Yue Z; Tsai CC; Shen J
    J Am Chem Soc; 2019 Apr; 141(16):6553-6560. PubMed ID: 30945531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.